Addex Therapeutics ADXN
NASDAQ ADXN
$3.07 +0.09 (+3.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

Addex Therapeutics (ADXN) Net Equity Issued and Repurchased (2021 - 2023)

Updated

Addex Therapeutics (ADXN) posted Net Equity Issued and Repurchased of $36.49 million for FY2024, up 847.0% from $3.85 million in FY2023.

Analysis

Addex Therapeutics (ADXN) Net Equity Issued and Repurchased (2021 - 2023) Analysis & Trends

Since FY2018, Addex Therapeutics has reported Net Equity Issued and Repurchased for 5 years.

  • Annual Net Equity Issued and Repurchased shows a three-year compound annual growth rate of 49.1% (FY2021 to FY2024).
  • The FY2024 figure stands as the highest annual Net Equity Issued and Repurchased since FY2018.
  • Business Quant data shows ADXN's Net Equity Issued and Repurchased at $3.85 million in FY2023 (+29.5%), $2.98 million in FY2022 (-73.0%) and $11.02 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 6.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 9.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Addex Therapeutics 2.67 Mn 2.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 24,132.15
Sep 30, 2023 10,449.77
Dec 31, 2022 26,200.71
Mar 31, 2021 11.24 Mn
API Access

Addex Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ADXN&period=max&api_key=YOUR_API_KEY